-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Accendra Health, Lowers Price Target to $4

Benzinga·01/09/2026 15:52:46
Listen to the news
Citigroup analyst Daniel Grosslight maintains Accendra Health (NYSE:ACH) with a Buy and lowers the price target from $7 to $4.